Halotherapy in Treatment of Consequences of Pulmonary Pathology (Thoracic Pathology): Effectiveness, Optimal Use in Modern Conditions

The healthcare sector is faced with the need to find new innovative and multidisciplinary approaches for the prevention and treatment of Covid, post-Covid, long-Covid, chronic, comorbid disorders. The results of 30 years of experience in the use of halotherapy in the treatment of pulmonary pathology indicate that the authors of the article have established the optimal level of use of halotherapy in pathological pulmonary processes. At the same time, clinical experience provides evidence for the optimal method of using the halotherapy method in pulmonary nosologies. The method of using salt therapy in exudative pleurisy, in fibrinous pleurisy, in fibrotic processes in the lungs has been theoretically substantiated, developed, and implemented in clinical practice. It has been proven that halotherapy is an effective treatment method for bronchial asthma, chronic obstructive pulmonary diseases, acute respiratory viral infections, fibrinous and exudative pleurisy. The therapeutic effect of this method is observed only when using halogenerators with the ability to grind salt in the range of 1-5 microns. Halotherapy sessions in patients with bronchial asthma with mild and moderate severity lead to the development of nonspecific hyposensitization, which in turn provides long-term remission of attacks and reduces the need for glucocorticosteroid drugs. Halotherapy has a confirmed immunomodulatory effect and activates local and T-cell immunity. It requires further study of the experience of halotherapy, conducting marketing, pharmacoeconomic and comparative analysis.